Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry.

× No keyword cloud information.

13 in total

Review 1. The antipsychotic potential of muscarinic allosteric modulation.

Authors: Thomas M Bridges; Evan P LeBois; Corey R Hopkins; Michael R Wood; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley
Journal: Drug News Perspect Date: 2010-05

Review 2. The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy.

Authors: Holly Moore
Journal: Schizophr Bull Date: 2010-09-24 Impact factor: 9.306

Review 3. Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies.

Authors: Jim R Fadel
Journal: Behav Brain Res Date: 2010-02-16 Impact factor: 3.332

Review 4. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors: Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal: Nat Rev Drug Discov Date: 2009-09 Impact factor: 84.694

Review 5. Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.

Authors: Bruce J Melancon; James C Tarr; Joseph D Panarese; Michael R Wood; Craig W Lindsley
Journal: Drug Discov Today Date: 2013-09-17 Impact factor: 7.851

6. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis.

Authors: Rafael Segarra; Arantzazu Zabala; Jose Ignacio Eguíluz; Natalia Ojeda; Edorta Elizagarate; Pedro Sánchez; Javier Ballesteros; Miguel Gutiérrez
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2010-09-14 Impact factor: 5.270

Review 7. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.

Authors: Daniel C Javitt; Robert Freedman
Journal: Am J Psychiatry Date: 2014-11-17 Impact factor: 18.112

Review 8. Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments.

Authors: Martin Sarter; Cindy Lustig; Stephan F Taylor
Journal: Neuropharmacology Date: 2010-12-13 Impact factor: 5.250

Review 9. Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Authors: Jared W Young; Susan B Powell; Mark A Geyer
Journal: Neuropharmacology Date: 2011-06-29 Impact factor: 5.250

10. Pharmacologic treatment of first-episode schizophrenia: a review of the literature.

Authors: Shibu P Thomas; Harpal Sing Nandhra; Swaran P Singh
Journal: Prim Care Companion CNS Disord Date: 2012-01-05